Global Partnerships Zydus is expanding internationally through partnerships such as Sakar Healthcare for oncology products in GCC and emerging markets and Algorae Pharmaceuticals for a broad medicines portfolio in Australia and New Zealand. This creates channels for co marketing, distribution, and potentially contract manufacturing partnerships. Target regional distributors, hospital networks, and government procurement programs to capitalize on these growth channels.

Oncology and Diagnostics Recent moves in oncology collaborations and the Shield blood based multi cancer detection test in India indicate a growth axis in cancer care. Opportunity to bundle diagnostics with therapeutics, pursue co marketing with clinics and labs, and expand into GCC and other markets with oncology portfolios.

Financial Momentum Solid revenue growth and improving profitability indicate capacity to scale manufacturing and pursue long term supply agreements. Leverage this momentum to win large contracts, secure strategic procurement arrangements, and expand capacity for in demand therapies including oncology and injectable medicines.

Manufacturing Footprint Strategic investments in manufacturing assets and selective divestments indicate capacity expansion and optimization. This opens opportunities for contract manufacturing, toll manufacturing, and exclusive supply arrangements with partners seeking reliable, scalable production capabilities.

Emerging Markets A strong presence in India with growing activity in GCC, Australia and New Zealand, and other emerging markets provides a broad platform for market entry of new products, regulatory navigation, and rapid distribution. Use this footprint to accelerate launch timelines and cross sell across therapy areas and diagnostics.